JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs
-
-
-
-
-
-
-
Buy any potential weakness in this big pharma stock: JPMorgan
-
-
-
-
-
-
-
Novo Nordisk's parent to buy Catalent for $16.5 billion to boost Wegovy supply
-
-
-
-
-
-
-
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK375 at JPMorgan
-
-
-
-
-
-
-
ABLYNX STRONGLY BELIEVES UNSOLICITED CONDITIONAL PROPOSAL FROM NOVO NORDISK FUNDAMENTALLY UNDERVALUES THE COMPANY AND ITS FUTURE PROSPECTS
-
-
-
-
-
-
-
Notable Analyst Rating Changes 05/14: (HMY) (P) (AKAM) Upgraded; (WAG) (NVO) (TNK) Downgraded
-
-
-
-
-
-
-
Notable Analyst Rating Changes 9/11: AXL, INTC, TXT, SLB, LVS, AVY Upgraded; AIG, BBY, ALL, NOK, RNWK Downgraded
-
299,886 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

